SHIRVAN MITCHELL (CSO and CDO) received a stock award from SILEXION THERAPEUTICS CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/8/2026ACC: 0001178913-26-003136
Officer· CSO and CDO
Since Feb 2026
+6K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+6K
Price / share
—
Trade value
—
% of position
215.1%
6/4/2026
2.79K→8.79K
Total
Net shares
+6K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/4/2026 | A · Award | +6K | — | — | 215.1% | 2.79K | 8.79K |
| Total | +6K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Stock Option (right to buy Ordinary Shares)
DirectUnderlying security
Ordinary Shares
Underlying shares
48.00
Shares owned
48.00
Exercise price
9077.10
Expiration
—
Exercise window
—
Total
Underlying
48.00
Owned
48.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy Ordinary Shares) Direct | Ordinary Shares | 9077.10 | — | — | 48.00 | 48.00 |
| Total | 48.00 | 48.00 | ||||